BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 18.11.2005

Request for Comment on the Status of Pyridoxamine

The Food and Drug Administration (FDA) is announcing that comments related to the status of pyridoxamine may be submitted until December 19, 2005. FDA is requesting comments in response to the submission of a citizen petition requesting, among other things, that the agency determine the status of pyridoxamine. All comments postmarked on or before December 19, 2005 will be accepted as part of the official record for this matter.

Source: Federal Register — Food and Drug AdministrationOpen original release →